Patent Term Application for FLYRCADO™ (flurpiridaz F 18), Patent No. 8,226,929 | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2025-E-0364

Patent Term Application for FLYRCADO™ (flurpiridaz F 18), Patent No. 8,226,929

Documents

Comments

Description

OPEN

Comment Period OpensFeb 4, 2025

Type	Title	Posted	Comments	Status
Other	Letter from U.S Patent and Trademark Office to FDA CDER	Mar 25, 2026	--

CDER

Patent Term Application for FLYRCADO

McAndrews, Held & Malloy, Ltd.

GE Healthcare Inc

(flurpiridaz F 18)

Patent No. 8,226,929

OPEN